Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for severe lupus myelopathy
ChiCTR-TNC-10000798Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rituximab in lupus myelitis, sponsored by Renji Hospital. Primary endpoints: BILAG index score, WISCI and 1 more. Started Jun 2007; status: completed.
02
Drugs
rituximab
03
Conditions
lupus myelitis
Beyond the preview
Go deeper on ChiCTR-TNC-10000798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000798.